Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciforadenant in adults with ADHD
NCT02253745Phase 2Completed
- Sponsor
- Vernalis
- Start
- Jul 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ciforadenant in attention deficit hyperactivity disorder (ADHD), sponsored by Vernalis. Started Jul 2013; status: completed.
02
Drugs
ciforadenant
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02253745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02253745.